Treprostinil sodium

This classification denotes a prostaglandin analogue and antihypertensive agent with the molecular formula C23H33O5.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7JZ75N2NT6, chemically known as acetic acid, (((1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-((3s)-3-hydroxyoctyl)-1h-benz(f)inden-5-yl)oxy)-, monosodium salt but more generally known as treprostinil sodium, which bears US NIH Compound Identifier 130880. European Medicines Agency schedules Treprostinil sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22911. Most nations, for tariff and trade purposes, schedule treprostinil sodium under HS 29375000 and SITC 54156. As of Q4 2014, TREPROSTINIL SODIUM remains US FDA's Preferred Term for this commodity. Treprostinil sodium bears US NLM identifiers UMLS ID C1101501 and NCI Concept Code C61984. SMILES: CCCCC[C@@H](CC[C@@H]1[C@H]2CC3CCCC(C3C[C@H]2C[C@H]1O)OCC(=O)[O-])O.[NA+].